Tveita et al. [28] revealed that ACKR2 levels tend to be elevated in COVID-19 patients relative to controls; moreover, they found similar increased levels in individuals infected with seasonal coronavirus or bacterial pneumonia. This evidence concerns the gene ACKR2 and COVID-19.